Clinical trial
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
NCT00003819
Study timeline
Study start (unknown)1998-06-01Date precision: month
Registry last updated2013-03-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
QS21BIOLOGICAL
TF(c)-KLH conjugate vaccineBIOLOGICAL
Thomsen-Friedenreich antigenBIOLOGICAL
keyhole limpet hemocyaninBIOLOGICAL
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00003819 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.